INTRODUCTION
The earliest events that occur following mucosal HIV-1 exposure remain poorly understood, largely because the eclipse period of infection prior to detectable viremia is very difficult to study in humans. Studies of the initial events of acute infection have therefore largely utilized the model of SIV infection in rhesus monkeys. Intravaginal SIV infection of rhesus monkeys has been reported to involve expanding foci of virus replicating in CD4+ T cells at the mucosal portal of entry during the first week of infection (Haase, 2005 (Haase, , 2010 Li et al., 2009a Li et al., , 2009b Miller et al., 2005; Zhang et al., 1999) , but little is known about the biology of early systemic virus dissemination. Innate cytokines and chemokines, such as MIP-3a, have also been reported to play a key role in recruiting CD4+ T cells to the site of inoculation to amplify the local expansion of the virus prior to distal spread (Li et al., 2009a) .
Viral engagement of cellular pattern recognition receptors (PRRs) trigger the production of type I interferons, which typically represent the first line of innate antiviral defense. Interferons have multiple downstream effects, including upregulation of antiviral restriction factors, such as MX2, TRIM-5, and APOBECs, which inhibit HIV-1 and SIV replication (Schoggins et al., 2011) . Nucleotide oligomerization and binding domain (NOD)-like receptors (NLRs) represent another family of genes that sense pathogens and regulate cellular functions, including antiviral defense (Kanneganti et al., 2007; Kofoed and Vance, 2011) . NLRs include both inflammasome activators (NLRP1 and NLRP3), which stimulate the production of proinflammatory cytokines, such as IL-1 and IL-18, and triggers of NFkB (NLRC-1 and NLRC-2), which augment inflammation (Thaiss and Elinav, 2015) . These proinflammatory NLRs are counterbalanced by other NLRs and other molecules that regulate inflammasome activity. These include anti-inflammatory NLRC3, NLRP6, NLRP12, and NLRX1 and transactivators of MHC II molecules, such as CIITA (Lukens et al., 2015; Moore et al., 2008; Parvatiyar and Cheng, 2011; Guo et al., 2016) . The complexity of the inflammasome highlights the importance of negative-feedback loops, in which some members of the inflammasome promote inflammation and others reduce inflammation.
Anecdotal evidence has suggested that the virus can disseminate rapidly to distal sites (Hu et al., 2000; Miller et al., 2005 ; Ribeiro Dos Santos et al., 2011), but the kinetics and extent of virus dissemination from the site of inoculation remain unknown, and the initial innate response to the virus in the first few days of infection is largely unexplored, both at the site of inoculation and at early sites of distal virus spread. Previous studies have reported type I interferon responses, IL-1 expression, and induction of cell death pathways (Hirao et al., 2014; Jakobsen et al., 2015) . However, prior studies have been limited by challenges in identifying the earliest sites of virus spread, which has largely precluded a detailed evaluation of the earliest host innate responses in viral RNA-positive distal tissues. A detailed characterization of the earliest host response to the virus is critical for a comprehensive understanding of initial viral pathogenesis and for the development of vaccines, microbicides, and therapeutics aimed at blocking HIV-1 infection.
In this study, we evaluated the kinetics of virus dissemination to distal tissues and the initial innate and adaptive host immune responses following intravaginal SIV infection of rhesus monkeys. Scheduled necropsies on days 0, 1, 3, 7, and 10 following intravaginal SIV inoculation allowed comprehensive assessments of virology, immunology, histopathology, and gene expression profiles across multiple tissues in each animal. By day 1, the virus was occasionally detectable in distal tissues, such as the gastrointestinal tract, in addition to the site of inoculation, and triggered proinflammatory transcriptomic responses, including nucleotide sensor components of the inflammasome. At both the site of inoculation and in viral RNA-positive distal tissues, increased expression of antiviral genes, including interferon-stimulated restriction factors, was notably absent on day 1 and was not consistently observed until peak viral replication on day 10. These data suggest a model for early SIV pathogenesis in which the virus triggers initial proinflammatory host responses that downregulate innate antiviral immunity, inhibit adaptive cellular immunity, and facilitate viral replication at sites of early distal dissemination.
RESULTS

Rapid Virus Dissemination from the Site of Inoculation to Distal Sites
We performed comprehensive serial necropsies in 44 rhesus monkeys (M. mulatta) on day 0 (n = 4), day 1 (n = 6), day 3 (n = 9), day 7 (n = 17), and day 10 (n = 8) following intravaginal inoculation of 5 3 10 4 TCID 50 SIVmac251 (Barouch et al., 2012; Liu et al., 2009 Liu et al., , 2010 . These animals did not express the protective MHC class I alleles Mamu-A*01, Mamu-B*08, or Mamu-B*17. All animals were cycling adult females with the exception of five juvenile animals in the day 7 group and three juvenile animals in the day 10 group, and inoculations were timed to avoid the menstrual phase. To establish a uniformly infectious but not overwhelming challenge dose, we performed a preliminary titration study and selected the dose that led to infection in 100% (8 of 8) of animals, while restricting the number of transmitted/founder viruses in plasma to a median of 5 (range 1-9), as assessed by single-genome amplification sequencing (data not shown).
In both the preliminary titration and serial necropsy studies, peak plasma viremia occurred in the majority of animals on days 10-14 following SIVmac251 infection, and the pre-viremic eclipse period was a median of 7 days ( Figure S1 ). Tissue viral RNA levels were quantitated using an ultrasensitive nested RT-PCR assay (Hansen et al., 2013 ) using 23-31 tissues obtained at necropsy for each animal, including the female reproductive tract, draining lymph nodes, gastrointestinal tract, distal lymph nodes, tonsil, spleen, bone marrow, thymus, lung, liver, and central nervous system.
We observed low levels of viral RNA in at least one tissue outside the female reproductive tract in 83% (5 of 6) animals necropsied on day 1 following challenge ( Figure 1 ; Data S1A). Viral RNA in the female reproductive tract presumably reflected the inoculum challenge virus. Low levels of viral RNA were also variably detected in duodenum, jejunum, ileum, colon, cecum, and rectum, as well as occasionally in genital/pelvic lymph nodes, spleen, and bone marrow of animals necropsied at this time point. Although most distal tissues remained viral RNA negative on day 1, the fraction of gastrointestinal tissues that were positive for viral RNA on day 1 following SIVmac251 inoculation was significantly greater than the very low background falsepositive rate observed in SIV-naive control animals (p = 0.006, Fisher's exact test; Figure 2 ), demonstrating that the virus had disseminated from the mucosal site of inoculation to distal anatomic sites within the first 24 hr.
In monkeys necropsied on day 3, 89% (8 of 9) animals had detectable levels of viral RNA in at least one distal tissue, including the gastrointestinal tract, draining and distal lymph nodes, tonsil, spleen, bone marrow, thymus, lung, liver, and central nervous system (Figure 1 ). Wide variations in levels of viral RNA in multiple tissues were observed in monkeys necropsied on day 7, and high levels of viral RNA were observed in the majority of animals necropsied on day 10, particularly in the gastrointestinal tract and lymphoid tissues, consistent with previous descriptions of acute infection (Brenchley et al., 2004; Li et al., 2005; Mattapallil et al., 2005) . Viral DNA was also detected in a progressively greater proportion of tissues in animals necropsied on days 3, 7, and 10 (Data S1B).
Immunohistochemistry and in situ hybridization for viral RNA were also performed in multiple tissues in each animal. We did not observe foci of viral replication in the female reproductive tract or in distal tissues at the early time points (data not shown), possibly because of the limited sensitivity of these assays and that the levels of viral RNA in tissues in this study were lower than those observed in previously published experiments (Li et al., 2009a; Miller et al., 2005; Zhang et al., 1999) .
Initial T Lymphocyte Responses by Day 7 in Mucosal Tissues and Bone Marrow
We evaluated SIV Gag-specific CD8+ and CD4+ T lymphocyte responses in 23 distinct tissues in each monkey by multiparameter flow cytometry (Data S1C) (Baden et al., 2015; Li et al., 2011) . SIV Gag-specific T lymphocyte responses were first observed on day 7 in a subset of animals in female reproductive tract mucosa, gastrointestinal mucosa, and bone marrow, but not in lymph nodes or peripheral blood (Figure 3 ; Data S1D). On day 10, all monkeys exhibited high-frequency Gag-specific T lymphocyte responses in these tissues, but no responses were observed in peripheral blood at this time point. These data demonstrate that antiviral cellular immune responses initially develop in tissue effector sites during acute infection prior to the emergence of responses in the periphery, but this occurs ''too little and too late'' (Haase, 2010; Reynolds et al., 2005) , after the virus has already widely disseminated (Figure 1 ). Humoral immune responses were not detected at these early time points (data not shown).
Systemic Transcriptional Changes Occur by Day 1, Following SIV Infection, and Highlight a Potent Inflammatory Response Next, we performed transcriptional profiling in multiple tissues in each animal at necropsy to identify the earliest evidence of the host sensing the virus by analyzing gene expression changes following SIVmac251 inoculation. cDNA synthesized from RNA extracted from each tissue was hybridized to HT-12 V4 BeadChips and quantified using an Illumina iScan System. This approach provided >50% coverage of the rhesus transcriptome (Fukazawa et al., 2012) . Multidimensional scaling plots revealed that the largest transcriptomic variance between specimens was driven by tissue type (Data S1E). To correct for any potential tissue-specific bias, we pooled tissues into groups that exhibited similar transcriptomic profiles: female reproductive tract (FRT), gastrointestinal tissue (GI), lymph nodes (LN), and peripheral blood. These groupings were based on Euclidian distances of the transcriptomic signals and are shown in a dendrogram based on hierarchical clustering (Data S1E). The time of necropsy accounted for the second largest transcriptomic variance.
Gene expression profile changes indicative of activation of innate immune responses were evident by day 1 following SIVmac251 inoculation as compared with uninoculated controls in all tissues analyzed (FRT, GI, LN, and blood) ( Figure S2 ). These changes included substantial numbers of differentially Tissue viral RNA (log RNA copies /10 8 cell equivalents) across multiple tissues at necropsy in animals on days 1, 3, 7, or 10 following inoculation with SIVmac251.
The colors on each plot reflect individual animals. Values plotted below the horizontal line indicate samples in which viral RNA was not measured above the threshold of detection, which varied depending on the amount of each tissue analyzed. See also Figure S1 and Data S1.
expressed genes, as well as activation of innate immune pathways. We observed particularly striking differences in transcriptomic profiles in viral RNA-positive versus viral RNA-negative gastrointestinal and lymph node tissues obtained from the same animals at the same time on days 1 and 3 ( Figure S3 ). This finding allowed a focused evaluation of the nature of the earliest host innate immune responses to initial disseminated virus specifically in viral RNA-positive tissues.
Early Activation of the Inflammasome in Viral RNAPositive Tissues We analyzed transcriptomic profiles specifically in viral RNApositive tissues following SIVmac251 challenge to gain mechanistic insight into the initial host responses to the virus. As early as day 1 following infection, pathway analysis confirmed the induction of interferon signaling in viral RNA-positive tissues, although it is unclear if these initial transcriptomic changes required viral replication. Analysis of antiviral interferon-stimulated genes (ISGs) in viral RNA-positive tissues showed that several ISGs (CCR2, CCR6, and CXCR4) were upregulated on days 1 and 3, but importantly these did not include antiviral restriction factors, such as ISG15, IRF7, APOBEC, MX2, and TRIM5, until peak viral replication on day 10 (p = 0.02; Figures   4A and S4) . Components of the inflammasome were strongly upregulated on day 1 in the female reproductive tract as compared with uninoculated controls (p = 4.1 3 10 À4 ; Figure 4B ), as well as on day 1 in viral RNA-positive as compared with viral RNA-negative gastrointestinal tissues from the same animals (p = 3.2 3 10 À3 ; Figures 4B and S4 ). We compared female reproductive tract tissues from day 1 with uninoculated controls rather than day 1 viral RNA-negative tissues since nearly all female reproductive tract tissues were viral RNA-positive on day 1, presumably reflecting the inoculum challenge virus. This day 1 proinflammatory transcriptomic signature was observed in all viral RNA-positive tissues analyzed (FRT, GI, LN, and blood), but was not seen in similar tissues from uninfected animals ( Figure S5 ). Integrating the different tissue signatures generated a common day 1 signature in viral RNA-positive tissues. These data show a robust day 1 proinflammatory gene expression signature in both local tissues and viral RNA-positive distal tissues within 24 hr following intravaginal SIVmac251 inoculation (p = 5 3 10 À8 ; Figure 4C) . This common signature revealed upregulation of genes of the NFkB pathway, pro-inflammatory chemokines (CCL3), and genes expressed by monocytes/macrophages (CD14) and NK cells (TYROBP). The expression of this day 1 proinflammatory signature was also accompanied by the upregulation of several NLRs, including anti-inflammatory NLRs (NLRX1), and several genes of the anti-inflammatory TGF-b pathway (MAP4K4, TAB2, and PPP1R15A). Importantly, expression of the day 1 signature correlated inversely with the antiviral ISG signature (p = 3 3 10 À6 ; Figure 4D ) and correlated directly with the inflammasome signature (p = 7 3 10 À7 ; Figure 4D ) across all animals in this study. Consistent with these findings, expression of NLRX1 also correlated inversely with expression of IRF7, a key antiviral ISG (p = 0.02; Figure 4E ).
NLRX1 Expression Correlates with Early Virus
Replication NLRX1 is a negative regulator of the inflammasome pathway that inhibits expression of antiviral ISGs, IRF7, RIG-I, and TLRs (Allen et al., 2011; Moore et al., 2008; Guo et al., 2016) and was a component of the day 1 transcriptomic signature (arrow, Figure 4C) . NLRX1 expression also correlated inversely with antiviral ISG expression at the site of inoculation (p = 0.02; Figure 5A ) and correlated directly with the magnitude of viral RNA in gastrointestinal tissues at multiple time points (p = 2.6 3 10 À3 , Pearson correlation test; Figures 5B and 5C ). Moreover, the subset of animals with the highest NLRX1 expression also demonstrated the highest levels of viral RNA (p = 4.3 3 10 À3 ; Wilcoxon ranksum test; Figure 5D ). Multiple additional NLRs (NLRP5, NLRP6, NLRP8, and NLRC4) were also upregulated in addition to NLRX1 ( Figures 5B and S4 ). NLRX1 gene upregulation was confirmed by western blot for NLRX1 protein expression (p = 0.016) and demonstrated an inverse correlation with IRF7 protein expression (p = 0.008) ( Figures S6A and S6B) , consistent with the transcriptomics data ( Figure 4E ). NLRX1 exerts its anti-inflammatory activity by inhibiting expression of NFkB. We observed that NLRX1 expression correlated directly with expression of NFKBIA (p = 1.2 3 10 À3 ), the inhibitor of NFkB, and inversely correlated with expression of NFKB1 (p = 1.7 3 10 À7 ; Figures 4C, S6C , and S6D). These data suggest that the initial host response to the virus, both at the local site of inoculation and at sites of early distal virus spread, was characterized by a potent proinflammatory response and a negative-feedback loop highlighted by the induction of NLRX1, which may have suppressed expression of antiviral restriction factors and thereby facilitated viral replication.
Early Transcriptomic Changes Are Observed in NK Cells, Monocytes, and T Cells Gene set enrichment analysis (GSEA) using Nakaya modules (Nakaya et al., 2011; Subramanian et al., 2005) was performed to assess the contribution of various cell subsets within the analyzed mixed cell populations in each tissue to the observed early transcriptomic changes. Interestingly, NK cell-specific genes were upregulated in all analyzed tissues on days 1 and 3 following SIVmac251 inoculation ( Figure 6A ) and included NLRX1, KIR2DL4, and KIR2DL3 ( Figure 6B ), suggesting that NK cells contributed substantially to the early innate response to the virus. We defined a common NK-specific gene expression signature that was upregulated in all tissues on days 1 and 3 ( Figures S7A and S7B) . Monocyte-specific genes (CD14, CD83, FCER1G, and CSF3R) were also upregulated in the female reproductive tract, and T cell-specific genes (MAF, CD6, and CCR7) were upregulated in lymph nodes at these early time points (Figures 6A and 6B ). Moreover, we observed a significant correlation between expression of these genes in NK cells, monocytes, and T cells and viral RNA levels in tissues (Figures 6C-6E ). These results suggest that SIVmac251 infection triggered proinflammatory transcriptomic profiles, particularly in these cell subsets, which likely facilitated virus replication.
The TGF-b Pathway Negatively Regulates Adaptive T Lymphocyte Responses Next, we defined transcriptomic signatures associated with early virus-specific CD8+ and CD4+ T lymphocyte responses in gastrointestinal tissues. Since virus-specific T lymphocyte responses were first detected on day 7 (Figure 2 ), we first addressed this question utilizing tissues from days 7 and 10 following SIVmac251 challenge. By GSEA, the pathways that showed the strongest direct correlation with SIV-specific CD8+ T lymphocyte responses in tissues were metabolic pathways involved in T cell activation, including oxidative phosphorylation, adipogenesis, fatty acid metabolism, and xenobiotic metabolism ( Figure 7A ). In contrast, immune regulation pathways, including TGF-b and IL-2/STAT5 signaling, correlated inversely with antigen-specific T lymphocyte responses ( Figure 7A ). Upregulation of genes downstream of the anti-inflammatory TGF-b signaling pathway (Chen et al., 2005) was observed not only in viral RNA-positive tissues on days 7 and 10 but also in viral RNA-positive tissues as early as day 1 (Figures 7B and 7C ), suggesting that triggering of the TGF-b pathway was an early event. The early TGF-b signaling genes that were upregulated by day 1 included MAP3K7, which regulates TGF-b signaling, and FNTA (farnesyl transferase-a), which is an effector anti-inflammatory gene ( Figures 7B, 7C , and S7C). These data suggest that upregulation of TGF-b signaling occurred rapidly in response to the virus and preceded the generation of detectable Gag-specific T lymphocyte responses. The negative impact of TGF-b expression on CD8+ and CD4+ T lymphocyte responses was confirmed by linear regression analyses showing that TGIF1, a master positive regulator of the TGF-b pathway, as well as other TGF-b response genes inversely correlated with the magnitude of CD8+ and CD4+ T lymphocyte responses on days 7 and 10 in gastrointestinal tissues (p = 5.4 3 10 À5 and 6.3 3 10 À5 , respectively; Figure 7D ).
In contrast, SMAD7, a key negative regulator of TGF-b responses (Monteleone et al., 2001 (Monteleone et al., , 2008 , directly correlated with CD8+ and CD4+ T lymphocyte responses (p = 4.0 3 10 À4 and 7.0 3 10 À6 , respectively; Figure 7E ). Moreover, the magnitude of Gag-specific CD8+ T lymphocyte responses across all tissues inversely correlated with TGIF1 expression (R = À0.62, p = 1.8 3 10 À4 ; Figure 7F ) and directly correlated with SMAD7 expression (R = 0.75, p = 1.3 3 10 À6 ; Figure 7G ).
These data show that the TGF-b pathway was triggered rapidly in viral RNA-positive tissues and correlated with lower levels of adaptive T lymphocyte responses. Taken together, these findings show that the early proinflammatory host responses in viral RNA-positive tissues correlated with suppressed innate and adaptive immunity, likely resulting in increased viral replication. 
DISCUSSION
In this study, we describe a comprehensive picture of early mucosal SIV infection of rhesus monkeys at a substantially greater level of detail than previously reported. Integrated virologic, immunologic, and transcriptomic data from multiple tissues from the first few days following intravaginal SIV challenge demonstrate the rapid kinetics of virus dissemination from the site of inoculation to distal tissues, the initial development of virus-specific T lymphocyte responses in tissues, and the proinflammatory early innate host response to the virus. These findings support a model of early SIV pathogenesis in which at least a limited amount of the virus can rapidly disseminate to distal tissues by 24 hr following inoculation and induce robust expression of components of the inflammasome, as well as NLRX1, which suppresses antiviral restriction factors (Allen et al., 2011; Moore et al., 2008; Guo et al., 2016) , both at the mucosal portal of entry and in viral RNA-positive distal tissues. Classic antiviral restriction factors were not observed until day 10 in the context of overwhelming peak viral replication. The TGF-b pathway, which suppresses adaptive immune responses (Chen et al., 2005) , was also induced early in viral RNA-positive tissues and correlated with reduced T lymphocyte responses. Taken together, these data suggest that the virus triggers host responses in the first few days following infection and that these responses may suppress the generation of antiviral innate and adaptive immunity, thus facilitating its own replication. Previous studies have suggested the importance of chemokines, such as MIP-3a, for recruiting CD4+ T lymphocyte target cells to the site of inoculation, and glycerol monolaurate, which inhibits MIP-3a and other cytokines, was reported to protect against intravaginal SIV infection (Li et al., 2009a) . Inflammatory cytokines, such as IL-1, have also been reported in the gastrointestinal tract within 3 days of SIV infection (Hirao et al., 2014) . The present study extends these prior reports by comprehensively assessing the early host innate responses in viral RNA-positive tissues in the first few days following intravaginal SIV infection.
In particular, our data highlight the role of the inflammasome in early SIVmac251 pathogenesis as early as 1 day following infection. We speculate that NLRX1 is part of a negative-feedback loop triggered by the proinflammatory milieu in viral RNA-positive tissues (Moore et al., 2008; Parvatiyar and Cheng, 2011) . NLRX1 expression correlated inversely with expression of antiviral restriction factors (Figure 4 ) and correlated directly with levels of viral RNA ( Figure 5 ) and likely was expressed by tissue NK cells (Figure 6 ). Moreover, the early induction of the TGF-b pathway inversely correlated with Gag-specific CD8+ T cell responses (Figure 7) , suggesting that the virus may have hindered the induction of effective adaptive cellular immune responses at sites of early virus replication. This possibility is supported by the observation that expression of SMAD7, which is involved in downregulating the TGF-b pathway, was associated with higher Gag-specific CD8+ T cell responses (Figure 7 ). These findings suggest that the virus activates negative-feedback pathways that impede host antiviral innate and adaptive immune responses in the first few days following infection.
The early virus dissemination observed in the present study extends prior reports Zhang et al., 1999) by showing that low levels of the virus are detectable in at least some distal tissues in nearly all animals within 24 hr following intravaginal SIVmac251 challenge. These low levels of the virus were sufficient to trigger profound transcriptomic changes in these viral RNA-positive tissues, resulting in a local milieu that favors viral replication. These data also suggest that the ''window of vulnerability'' to contain or to eliminate the virus at the mucosal portal of entry is more limited than previously appreciated (Haase, 2005 (Haase, , 2010 . HIV-1 vaccination and other prevention strategies should take into account the ability of the virus to disseminate rapidly to distal tissues and to suppress host antiviral innate and adaptive immune responses.
Significant differences exist between this experimental model of SIV infection in rhesus monkeys and HIV-1 infection in humans. In particular, we utilized a dose of the virus that infected 100% of monkeys with a single inoculation, which is substantially higher than typical human HIV-1 exposures. However, this dose was not overwhelming, as it still resulted in a substantial genetic bottleneck of transmitted/founder viruses. Moreover, this dose of the virus resulted in kinetics and magnitudes of acute viremia that were comparable to lower limiting doses of this challenge virus (Liu et al., 2010) .
Our findings have important implications for our understanding of HIV-1 pathogenesis and for the development of HIV-1 prevention strategies. The detailed picture of the kinetics of early virus spread and the nature of the early host innate immune responses suggest that the eclipse period is far more complex and dynamic than previously recognized. Moreover, the virus appears to trigger host responses in the first 24 hr that may inhibit the generation of antiviral innate and adaptive immunity and thus may facilitate its own replication. Our data also provide a detailed picture of acute SIV infection in rhesus monkeys that may help guide future studies to assess the protective efficacy of vaccines, antibodies, drugs, and other preventative interventions.
EXPERIMENTAL PROCEDURES Animals 44 outbred, Indian-origin adult or juvenile female rhesus monkeys (Macaca mulatta) were genotyped and selected as negative for the protective MHC class I alleles Mamu-A*01, Mamu-B*08, and Mamu-B*17. TRIM5 polymorphisms were balanced equally among groups, and animals were otherwise randomly allocated. All monkeys were housed at Bioqual. Animals were infected with 5 3 10 4 TCID 50 of our SIVmac251 challenge stock (Barouch et al., 2012; Liu et al., 2009 Liu et al., , 2010 by the intravaginal route and were necropsied on days 0, 1, 3, 7, or 10 following infection. At necropsy, multiple samples of 23-37 tissues were obtained for virology, immunology, histopathology, and gene expression profiling. All animal studies were approved by the appropriate Institutional Animal Care and Use Committee (IACUC).
Viral RNA and DNA Plasma SIV RNA levels were measured using a gag-targeted quantitative realtime RT-PCR assay, and the tissue levels of SIV RNA and DNA were measured using gag targeted, nested quantitative hybrid real-time/digital RT-PCR and PCR assays, essentially as previously described (Hansen et al., 2013) .
Cellular Immune Assays
SIV-specific cellular immune responses in blood and tissues were assessed by multiparameter intracellular cytokine staining (ICS) assays essentially as previously described (Baden et al., 2015; Barouch et al., 2012; Li et al., 2011) . Nine-color ICS assays were performed with predetermined titers of monoclonal antibodies (mAbs) against CD3 (SP34; Alexa700), CD4 (L200; AmCyan), CD8 (SK1; allophycocyanin-cyanine 7 [APC-Cy7]), CD28 (L293; peridinin chlorophyll-A-cyanine 5. Transcriptomic Analysis Cells were isolated from tissues and lysed for RNA extraction (QIAGEN). Reverse transcription reactions were performed to obtain cDNAs, which were hybridized to the Illumina Human HT-12 (v.4) Expression BeadChip in accordance with the manufacturer's instructions and quantified using an Illumina iScan System. Data were collected with the Illumina GenomeStudio software. Analysis of the genome array output data was conducted using the R statistical language and the Limma statistical package from Bioconductor (Gentleman et al., 2004) . First, arrays displaying unusually low median intensity, low variability, or low correlation relative to the bulk of the arrays were tagged as outliers and were discarded from the rest of the analysis.
Quantile normalization, followed by a log2 transformation using the Bioconductor package LIMMA, was applied to process microarrays. The LIMMA package was used to fit a linear model to each probe and to perform a moderated Student's t test on various differences of interest between tissue types and time points. For data mining and functional analyses, genes that satisfied a p value < 0.05 were selected. Probes that did not map to annotated RefSeq genes and control probes were removed. When indicated, the expected proportions of false positives (FDR) were estimated from the unadjusted p value. 697 total samples from 34 monkeys were analyzed. Transcriptomic data and correlations with virologic and immunologic data were analyzed by heatmaps, F-tests, gene set enrichment analyses (GSEA) (Subramanian et al., 2005) , GeneMANIA networks (Mostafavi and Morris, 2010; Mostafavi et al., 2008) , and module analyses (Merico et al., 2010) .
Western Blots
Lymph node mononuclear cells from uninfected monkeys, as well as monkeys identified as NLRX1 high or NLRX1 low by transcriptomics were washed twice in PBS. Mitochondrial and soluble nuclear extracts were prepared using the Subcellular Protein Fractionation Kit for Cultured Cells (Thermo Scientific), and protein concentrations were determined by Bradford assays. 25 mg of the mitochondrial extracts and 15 mg of the nuclear extracts were resolved by 10% SDS-PAGE (Mini Protean TGX Precast Gels, Biorad) and transferred onto a methanol-activated polyvinylidene fluoride membrane for 1 hr at a constant voltage of 100 V. The membranes were blocked with 5% BSA and incubated with specific mAbs overnight. Mitochondrial lysates were probed with NLRX1 (Aviva Systems Biology, 1:100) and VDAC (Cell Signaling, 1:1,000). Soluble nuclear extracts were probed for phosphorylated IRF7 and TATA binding protein (TBP) (Cell Signaling, 1:1,000 for both). Detection of the target proteins utilized Pierce ECL Plus Western Blotting Substrate (Thermo Scientific), followed by autoradiography (USA Scientific). For densitometric scanning, band intensities for the experimental samples were normalized with the corresponding loading controls (VDAC for NLRX1, TBP for IRF7) and expressed as percent arbitrary unit (% AU).
Statistics
To estimate differences in mean tissue viral RNA of each experimental group in comparison to the naive group, we applied linear mixed effects models.
Observations from the same animal were treated as a cluster, and a random intercept was prescribed for each animal in the model. p values for the differences were estimated for each tissue group. Mean log 10 levels of viral RNA were calculated and plotted by day and tissue group. We utilized logistic regression models to estimate the probabilities that each tissue type was positive for viral RNA. Observations from the same experimental animal were treated as an independent cluster. The probabilities were estimated and plotted by day and tissue group. To assess whether the proportions of each experimental group differed from those of the naive group, we used Fisher's exact tests. Tests were carried out separately for each tissue group.
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Transcriptomics data can be accessed at GEO: GSE80013 and NCBI: 17831466. 
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